Michael Milken
Founder & Chairman
“By the time I was diagnosed with advanced prostate cancer in 1993, I thought I knew a lot about cancer. So the shock of my diagnosis was compounded by the realization that I knew almost nothing about prostate cancer. I still shudder at the thought of what would happen if I hadn’t insisted on the PSA test even though I felt fine.”
Constructing Our Strategy
Michael Milken Establishes CaP CURE and Declares War on Prostate Cancer
More than thirty years ago, PCF—originally founded as CaP CURE—began its mission to redefine the landscape of prostate cancer research funding.
Mobilizing Awareness & Funding Research
March in Washington spurs Congress to double the NIH Funding
Hundreds of thousands of participants, including representatives from 600 disease organizations, gathered on the National Mall and across the country to demand increased research funding. Mike Milken played a key role in organizing the event, bringing together advocates and researchers. Later that year, Congress passed legislation to more than double the National Institute of Health budget over the next five years.
A Community of Collaboration
Accelerating the Understanding of Prostate Cancer and Treatment Landscape
PCF has transformed the field of prostate cancer research by pioneering a new funding model. We apply three forms of investments to make progress towards our goals of extending lives and improving quality of life: Scientific, Human, and Social.
The Work We Fund
Our Partnership with Veteran Affairs
$65 Million Public Private Partnership to Deliver Precision Oncology
The partnership establishes multiple PCF-VA Centers of Excellence (now 14 and counting) across the nation. These centers advance cutting-edge medical research, deliver new genomic treatments, and provide a road map to apply precision medicine solutions for all forms of cancer.